Caelyx™ in malignant mesothelioma: A phase II EORTC study
Open Access
- 1 June 2000
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 11 (6) , 697-700
- https://doi.org/10.1023/a:1008346925273
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- A phase II study of gemcitabine in patients with malignant pleural mesotheliomaCancer, 1999
- Malignant pleural mesotheliomaAnnals of Oncology, 1998
- Efficacy of pegylated-liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma after failure of standard chemotherapy.Journal of Clinical Oncology, 1997
- Paclitaxel for malignant pleural mesothelioma: a phase II study of the EORTC Lung Cancer Cooperative GroupBritish Journal of Cancer, 1996
- High-dose methotrexate in the treatment of malignant mesothelioma of the pleura. A phase II studyBritish Journal of Cancer, 1992
- Epirubicin in malignant mesothelioma: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.Journal of Clinical Oncology, 1992
- Mitoxantrone in malignant pleural mesothelioma: A study by the EORTC lung cancer cooperative groupEuropean Journal of Cancer and Clinical Oncology, 1991
- The role of extrapleural pneumonectomy in malignant pleural mesotheliomaThe Journal of Thoracic and Cardiovascular Surgery, 1991
- The Treatment of Malignant Mesothelioma of the PleuraAmerican Journal of Clinical Oncology, 1990
- A phase II evaluation of cisplatin in unresectable diffuse malignant mesothelioma: A Southwest Oncology Group StudyInvestigational New Drugs, 1988